DENGUE VACCINE DEVELOPMENT

Award Information

Agency: Department of Defense	Branch: Army	Award ID: 3977	Program Year/Program: 1988 / SBIR
Agency Tracking Number: 3977	Solicitation Year: N/A	Solicitation Topic Code: N/A	Solicitation Number: N/A

Small Business Information: HAWAII BIOTECH, INC.
99-193 AIEA HEIGHTS DRIVE, SUITE 200 AIEA, HI 96701-3900
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 2: Fiscal Year: 1988

Title: DENGUE VACCINE DEVELOPMENT

Agency / Branch: DOD / ARMY

Contract: N/A

Award Amount: $553,000.00

Abstract:
THE ULTIMATE OBJECTIVE OF THIS PROJECT IS THE PRODUCTION OF A DENGUE VACCINE. THE FOUR DENGUE VIRUSES (SEROTYPES) AS A GROUP ARE BY FAR THE MOST IMPORTANT VIRUSES TRANSMITTED TO MAN BY ARTHROPODS AND IN TERMS OF GLOBAL MORBIDITY ARE RESPONSIBLE FOR SEVERAL HUNDRED THOUSAND TO SEVERAL MILLION CASES ANNUALLY. IN PHASE I RANDOM FRAGMENTS OF THE DENGUE VIRUS 2 (RNA) GENOME WILL BE CLONED INTO A BACTERIAL EXPRESSION VECTOR. THESE RANDOMLY GENERATED FRAGMENTS WILL BE PRODUCED IN TWO WAYS TO ENSURE COMPLETE COVERAGE OF THE RNA GENOME.

Principal Investigator:
Morton Mandel
8084875565

Business Contact:

Small Business Information at Submission:

Hawaii Biotechnology Group Inc
99-193 Aiea Heights Dr Aiea, HI 96701

EIN/Tax ID:

DUNS: N/A

Number of Employees:

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No